ASMI supports change
September 1, 2011
THE Australian Self Medication
Industry has thrown its support
behind this week’s ANAO report
(see left), saying its recommendations
are in line with ASMI’s position over
the last few years.
“These measures will help to
strengthen the framework of
regulation in the sector by providing
more accurate and timely advice to
the public, and will help to protect
the credibility of those products
that are proven and evidencebased,”
said the Executive Director
of ASMI, Dr Deon Schoombie.
“This is a very timely and wellconsidered
report which has
provided the opportunity to help
the industry overcome the damage
that is incurred through products
without credible evidence to
support their claims,” Schoombie
added.
In addition to increasing postmarket
surveillance and ensuring
early detection of non-compliance,
ASMI said that there also need to
be penalties and sanctions in place
to act as an effective deterrent
against non-compliance.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Sep 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Sep 11
